Kyverna Therapeutics, Inc. Common Stock (KYTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$8
Day's range
$8.68

Kyverna Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GORDONMD GLOBAL INVESTMENTS LP 08/14/2026 4.24 M $37.82 M   0.00% 6.97%
GILEAD SCIENCES, INC. 08/03/2026 4.13 M $36.76 M   0.00% 6.78%
BLACKROCK, INC. 08/07/2026 3.13 M $27.93 M   257.41% 5.15%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 08/14/2026 2.89 M $25.71 M   -7.23% 4.74%
AIGH CAPITAL MANAGEMENT LLC 08/07/2026 2.80 M $24.91 M   39.79% 4.59%
DEERFIELD MANAGEMENT COMPANY, L.P. 08/14/2026 2.00 M $17.82 M   0.00% 3.28%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.90 M $16.91 M   6.40% 3.12%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.19 M $10.57 M   -23.74% 1.95%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.05 M $9.35 M   147.61% 1.72%
INSIGHT HOLDINGS GROUP, LLC 08/14/2026 989.05 K $8.81 M   0.00% 1.62%
MORGAN STANLEY 08/13/2026 982.31 K $8.75 M   0.51% 1.61%
STATE STREET CORP 09/22/2026 982.23 K $8.75 M   610.22% 1.61%
PROPEL BIO MANAGEMENT, LLC 08/13/2026 883.20 K $7.87 M   37.05% 1.45%
WOODLINE PARTNERS LP 08/14/2026 845.33 K $7.53 M   0.00% 1.39%
MILLENNIUM MANAGEMENT LLC 08/14/2026 639.78 K $5.70 M   -36.37% 1.05%
MBB PUBLIC MARKETS I LLC 08/14/2026 614.48 K $5.47 M   0.00% 1.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 500.00 K $4.46 M   0.00% 0.82%
D. E. SHAW & CO., INC. 08/14/2026 469.35 K $4.18 M   -34.96% 0.77%
WELLS FARGO & COMPANY/MN 08/14/2026 373.01 K $3.32 M   226.06% 0.61%
UBS GROUP AG 08/13/2026 365.57 K $3.26 M   -18.72% 0.60%
GOLDMAN SACHS GROUP INC 08/14/2026 335.23 K $2.99 M   57.45% 0.55%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 333.90 K $2.98 M   -9.14% 0.55%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 319.67 K $2.85 M   51.44% 0.52%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 319.67 K $2.85 M   100.00% 0.52%
NORTHERN TRUST CORP 08/13/2026 315.35 K $2.81 M   304.08% 0.52%
BNP PARIBAS FINANCIAL MARKETS 08/13/2026 310.63 K $2.77 M   -24.61% 0.51%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 282.19 K $2.51 M   100.00% 0.46%
BANK OF AMERICA CORP /DE/ 08/14/2026 265.41 K $2.36 M   376.25% 0.44%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 259.67 K $2.31 M   15.62% 0.43%
WALLEYE CAPITAL LLC 08/03/2026 245.59 K $2.19 M   542.97% 0.40%
Y-INTERCEPT (HONG KONG) LTD 07/14/2026 242.39 K $2.16 M   111.06% 0.40%
NUVEEN, LLC 08/11/2026 233.74 K $2.08 M   100.00% 0.38%
BURKEHILL GLOBAL MANAGEMENT, LP 08/14/2026 200.00 K $1.78 M   0.00% 0.33%
SIMPLIFY ASSET MANAGEMENT INC. 07/16/2026 182.60 K $1.63 M   5.49% 0.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 155.80 K $1.39 M   -73.03% 0.26%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 149.90 K $1.34 M   0.00% 0.25%
CITADEL ADVISORS LLC 09/02/2026 147.63 K $1.32 M   153.98% 0.24%
TD ASSET MANAGEMENT INC 08/04/2026 145.68 K $1.30 M   -13.84% 0.24%
STIFEL FINANCIAL CORP 08/12/2026 139.97 K $1.25 M   7.23% 0.23%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 123.65 K $1.10 M   -62.95% 0.20%
CITADEL ADVISORS LLC 09/02/2026 123.30 K $1.10 M   317.97% 0.20%
BARCLAYS PLC 08/14/2026 117.84 K $1.05 M   -13.59% 0.19%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 117.44 K $1.05 M   100.00% 0.19%
WESBANCO BANK INC 07/28/2026 110.30 K $982.77 K   0.00% 0.18%
JUMP FINANCIAL, LLC 08/13/2026 101.35 K $903.05 K   92.09% 0.17%
BANK OF NEW YORK MELLON CORP 08/06/2026 100.28 K $893.50 K   100.00% 0.16%
FMR LLC 08/13/2026 96.05 K $855.81 K   1,310.23% 0.16%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 96.05 K $855.79 K   -91.46% 0.16%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2026 88.85 K $791.61 K   219.06% 0.15%
SQUAREPOINT OPS LLC 08/14/2026 82.87 K $738.35 K   -43.62% 0.14%

Kyverna Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 154 institutional investors and hedge funds held shares of Kyverna Therapeutics Inc.. The most heavily invested institutionals were:

AIGH Capital Management LLC: 3.65 M

DIMENSIONAL FUND ADVISORS LP: 278,566

Simplify Asset Management Inc.: 182,603

Phoenix Wealth Advisors: 19,800

Creative Planning: 18,020

Ethic Inc.: 12,261

62.28% of Kyverna Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 49.84 M shares in the last 24 months. This purchase volume represents approximately $418.66 M in transactions.